ARCELL Sample Assessment Checklist

For an initial research discussion only; not the formal acceptance SOP. Use de-identified codes. Do not include patient names, medical-record numbers or IDs.

1. Study overview
Disease / research question:
Design (paired, longitudinal, single time point, other):
Approximate scope (distinguish cases, specimens and pairs):
Existing data:

2. FFPE / Arc-well
De-identified sample code:
Tissue site and time point:
Archival age:
Fixation and storage history (unknown if applicable):
Remaining tissue:
Available pathology, tumor fraction and necrosis information:
Primary-recurrence or pre/post-treatment pairing:
Available de-identified treatment and follow-up information:

3. Fresh tissue / wellDR-seq
Planned tissue type and source:
Planned collection time:
Preservation and transport proposal (confirm in advance):
Matched pathology and controls:
DNA-RNA relationship of interest:

4. Before execution
Applicable ethics approval / authorization:
De-identification, access rights and ownership:
Acceptance criteria to confirm:
Proposed QC and analytical scope:

Do not ship until transport and acceptance conditions are agreed. Suitability requires actual assessment.
Contact: research@arcell.bio